Get The Free Sample Complete
SWOT & PESTLE Analysis Report
This report is shared in order to give you an idea of what the complete SWOT & PESTLE analysis report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals. We also guarantee that you cannot find matched quality at such competitive and economic pricing.
Get Your Free Summary Copy of the
SWOT & PESTLE Analysis Report
Get the summary SWOT & PESTLE.com report delivered straight to your email inbox for free.
Our insightful and holistic reports have helped corporate,academia and researchers to take their research forward. Like us on Facebook to stay updated with the latest published SWOT & PESTLE Report.

Thermo Fisher Scientific SWOT and PESTLE Analysis

ID : 52317453| Mar 2018

COMPANY PROFILE -Thermo Fisher Scientific

Business Sector :Pharmaceuticals, Biotechnology

Operating Geography :United States, Global

About Thermo Fisher Scientific :

Thermo Fisher Scientific is a global leader in providing scientific solutions for a healthy, safe and clean world and is headquartered in Waltham, Massachusetts, US. Created in 2006 by merger of Fisher Scientific and Thermo Electron, the company deals in accelerating life science research, solving analytic challenges, improving patient diagnosis and delivering medicines which are in line towards achieving its mission statement of “enabling its customer to make the world healthier, cleaner and safer.” The company has approximately 75,000 employees globally and serves more than 400,000 customers as of 2017 and trades on NYSE as TMO.

Thermo Fisher Scientific Revenue :

$20.92 billion USD (FY ending 31st Dec 2017) – year on year growth of 14%

Competitive Analysis of Thermo Fisher Scientific

SWOT
PESTLE
The SWOT analysis for Thermo Fisher Scientific is presented below:
Strengths
Weaknesses
1. Excellent financial track record
2. Expansion through acquisitions
3. Wide geographical presence
4. Strong presence in emerging markets
5. Innovation driven
6. Good online presence
7. Wide range of products
1. Diverse and varied number of products which are heavily dependent on technology
2. Inability to successfully integrate new acquisitions
3. Heavy reliance on third party package-delivery-services
4. High leveraging
Opportunities
Threats
1. Expanding healthcare business
2. Growth of emerging markets
3. Tackling new types of diseases require innovative technologies
1. Economic uncertainty affects existing and potential clients negatively, which impacts business opportunities
2. Exchange rate risk
3. Different IPR rules in different countries
SWOT & PESTLE (combined)
Complete Report
USD 12.52
*
Great quality, Affordable pricing.
Safe and secure payments

Detailed SWOT Analysis of Thermo Fisher Scientific

Strength

This section is available only in the 'Complete Report' on purchase.

Weakness

1. Diverse and varied number of products which are heavily dependent on technology: The products and offerings of the company are very much diverse and heavily dependent on technology. Having a large array of products and services makes it difficult to provide focused attention to a specific product line or portfolio. Also, since their whole portfolio is heavily dependent on technology, a change in the technology can make their entire product range obsolete.

2. Inability to successfully integrate new acquisitions: The Company’s business strategy involves making forays into new products and markets by making acquisitions. The company has spent nearly $30 billion so far on such acquisitions. However, not all these acquisitions can be successfully integrated into the company and they might not align with the company’s existing vision, mission and objectives. Also, some of the acquisitions may have to be completed at a substantial premium over the fair value because of antitrust and regulatory approvals. These factors can adversely affect their business.

3. Heavy reliance on third party package-delivery-services: The Company delivers a sizable portion of their products through independent package delivery companies, such as FedEx and DHL. If one or more of these third-party package-delivery providers were to experience a major work stoppage, it could cause delays and incur additional costs to the company and could eventually lead to unpleasant customer relations.

4. High leveraging: As of December 31, 2015, the company had approximately $12.53 billion in outstanding debts. This makes them vulnerable to adverse economic and industry conditions, limiting their ability to obtain additional financing and acquiring new products and technologies through acquisitions.

Opportunity

1. Expanding healthcare business: Focus on healthcare is expanding globally and healthcare spending is consuming an escalating share of the household income across geographies. Since the company is having a strong focus on diagnostics and healthcare, this provides a huge opportunity for growth.

2. Growth of emerging markets: It is assumed that by 2025, the annual consumption in emerging markets will reach $30 trillion. Since Thermo Fisher has a strong presence in the emerging markets, especially in booming markets like China and India, the company is in a strong position to use this to its advantage.

3. Tackling new types of diseases require innovative technologies: Nowadays, we are witnessing the emergence of new and unknown diseases, such as the superbug and the zika virus. Since the company has specialty diagnostics and life science solutions and since the company’s growth strategy is focused on innovation, they can help the world get rid of such emerging threats by using the advance technology at their disposal. This can also create huge revenue generating opportunities.

Threat

This section is available only in the 'Complete Report' on purchase.

SWOT & PESTLE (combined)
Complete Report
USD 12.52
*
Great quality, Affordable pricing.
Safe and secure payments

Check out analysis of other relevant companies

TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
Copyrights and Disclaimer

Thermo Fisher Scientific SWOT and PESTLE analysis has been conducted by Nithin Krishnan and reviewed by senior analysts from Barakaat Consulting.

Copyright of Thermo Fisher Scientific SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.

Thermo Fisher Scientific SWOT and PESTLE Analysis
Price : USD 12.52